Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Highlights of the 22nd EACR meeting and tackling glioblastoma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 16.07.12
Views: 4964
Rating:

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain

Dr Joan Seoane talks to ecancer at EACR 22 in Barcelona about the highlights of the meeting and the need for advancement in treating glioblastoma.

 

Dr Seoane notes that all of the highlights at this year’s EACR meeting centered on tailored medicine and biomarkers to develop better treatment; with focus also given to translational research and getting information from the laboratory to the clinic quicker.

 

The meeting also alerted researchers and doctors to the importance to cancer stem cells and the metabolic impact of cancer and how this can be targeted.

 

In addition, Dr Seoane pays particular attention to glioblastoma and the need to work through collaborations to correct the insufficient treatment methods for this disease.

Related videos

follow us

NCRI 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation